Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 13 to 50

Methylprednisolone taper plus standard pain medicines after ACL repair

Official title: Efficacy of Methylprednisolone for Pain Control After ACL Repair: A Randomized Controlled Trial

Run by St. Louis University · NCT07158476 · Data updated 2026-11-12

We will try adding a methylprednisolone dose-pack to usual pain medicines after ACL repair to see if it lowers pain and reduces opioid use for people aged 13 to 50.

More Pain Management trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages13 Years to 50 Years
SexAll
Enrollment90 (estimated)
SponsorSt. Louis University
Academic / other
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedOctober 21, 2025
Main results expectedSeptember 2030
Study endsSeptember 2031
Registry record updatedOctober 24, 2025
Trial IDNCT07158476 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 13–50 undergoing primary ACL repair or reconstruction with autograft who can provide informed consent and do not meet the study's exclusion criteria.

Probably not a fit

Patients with revision or multi-ligament procedures, chronic opioid use, active infection, significant organ dysfunction, immune suppression, or contraindications to steroids/NSAIDs are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-center study enrolls consecutive patients aged 13–50 undergoing primary ACL repair or reconstruction with autograft and follows them for one year. Participants are randomized to a treatment pain regimen that includes a methylprednisolone dose-pack, meloxicam, hydrocodone/acetaminophen, and gabapentin, or to a control regimen of ketorolac, hydrocodone/acetaminophen, and gabapentin. Pain scores and daily opioid pill consumption are reported using the MyCap app the day of surgery and for the first 14–15 postoperative days, and clinic follow-ups occur at 2 weeks, 6 weeks, 12 weeks, and 1 year with collection of PROMs and complications. Demographic, comorbidity, and surgical data are collected from the medical record to compare outcomes between groups.

Why it matters

Potential benefit: If successful, adding a methylprednisolone taper could lower early postoperative pain and reduce opioid consumption and related harms after ACL repair.

How similar studies have gone: Short courses of corticosteroids have reduced pain and opioid use in some surgical settings, but using a methylprednisolone dose-pack after ACL repair in a randomized design is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient undergoing ACL repair or ACL reconstruction with tendon autograft
* Age 13-50 years old
* Able to provide informed consent or parent/legal guardian is able for minors

Exclusion Criteria:

* Concurrent and significant injury to other bones or organs (Injury Severity Score of 4 or greater)
* Revision ACL reconstruction
* Concomitant additional ligament reconstruction or high tibial osteotomy
* A history of alcohol abuse, substance abuse or chronic opioid use (filled opioid medication ×2 within 6 months of the surgery)
* A history of renal failure (\<60 mL/min/1.73 m2), liver dysfunction (child class, \>B), severe heart disease (NYHA Class 4), diabetes, neurological or psychiatric diseases that may affect pain perception, and pre-existing immune suppression.
* A history or active peptic ulcer disease, gastrointestinal bleeding, or current use of anticoagulation.
* Patients currently taking oral or injectable glucocorticoids and those who have taken either within 1 month of the procedure.
* Patients who are currently pregnant.
* Patients who are unable to undergo the multimodal pain standardized protocol including those with comorbidities or medical allergies precluding the use of corticosteroids, gabapentin, hydrocodone, acetaminophen, ketorolac, and/or meloxicam.

Where it's running

  • Saint Louis University
    St Louis, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.